MorphoSys AG, of Martinsried, Germany, appointed Ulrich Moebius head of preclinical development and project management...He also will provide strategic direction to Novacta's R&D team and will become chairman of the scientific advisory board...Pharminox Ltd., of Nottingham, UK, appointed Lee Arnold, Adrian Harris and Robert Jackson to its scientific advisory board

Anecova SA, of Geneva, named Barry W. Wilson, Patrick Aebischer and Jeffrey B. Jump to its board...ARCA biopharma Inc., of Broomfield, Colo., appointed Kathryn E. Falberg chief financial officer and chief operating officer...Gene Network Sciences Inc., of Cambridge, Mass., named Michael Gilman, founder and CEO of Stromedix Inc., to its board

New Leaf Venture Partners, of New York, named Srinivas Akkaraju managing director and to lead its West Coast biopharmaceuticals practice...OncoMethylome Sciences, of Liege, Belgium, named Gerard Vaillant to its board, and appointed Gert-Jan Renardel de Lavalette chief operating officer

Sander van Deventer, AMT's chief scientific officer and co-founder of the company, has been named interim CEO...Ligand Pharmaceuticals Inc., of San Diego, named Bruce A. Peacock and Steven J. Burakoff to its board...The company also added former FDA official Marianne Mann and former Merck & Co

The company also added former FDA official Marianne Mann and former Merck & Co...XOMA Ltd., of Berkeley, Calif., appointed Fred Kurland vice president of finance and chief financial officer

and Steve Neben senior director of project and alliance management...Oxigene Inc., of Waltham, Mass., named Nicole Onetto and Eric K. Rowinsky to the board of its subsidiary Symphony ViDA Inc

TyRx Inc., of Monmouth Junction, N.J., appointed William G. Dempsey an independent director. Vitae Pharmaceuticals Inc., of Fort Washington, Pa., promoted Tina Fiumenero to chief financial officer. XOMA Ltd., of Berkeley, Calif., appointed Stephen K. Doberstein vice president of research.

Prognostix Inc., of Cleveland, appointed Jake Orville president and CEO...Thomas Hecht was appointed chairman, and Michael Motschmann will join the board...SuppreMol also named Fritz Melchers and Falk Nimmerjahn to its scientific advisory board

NuPathe Inc., of Conshohocken, Pa., appointed Keith A. Goldan vice president and chief financial officer...PDL BioPharma Inc., of Redwood City, Calif., elected Paul W. Sandman and John P. McLaughlin to its board...Potential Pharmaceuticals, of Louisville, Ky., appointed Johanna M. Seddon and Janet Stoltz Sunness to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., appointed James J. O'Leary vice president and chief medical officer...Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted Adelene Q. Perkins president and chief business officer...It also appointed Bruce R. Thaw chairman and named James E. Rothman chairman of the scientific advisory board

Bioheart Inc., of Sunrise, Fla., appointed Matt Fendrich vice president of sales and marketing and named Alan P. Timmins to the board...Biovail Corp., of Toronto, appointed H. Christian Fibiger senior vice president and chief scientific officer of Biovail Laboratories International SRL...BioXcel Corp., of New Haven, Conn., added R. Christopher Seaton, Martha Matteo and Kevin Rakin to its corporate advisory board

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer

Arcxis Biotechnologies, of Pleasanton, Calif., named Christine Meda president and CEO...Calibrant Biosystems, of Gaithersburg, Md., appointed James Hawkins, Bethany Mancilla and Douglas Swirsky to its business advisory board...Lipoxen plc, of London, promoted Peter Laing to chief operating officer and appointed Ajay K. Agrawal head of business development

Tengion Inc., of East Norriton, Pa., named Mark Stejbach vice president of marketing and commercial planning...TheraGenetics Ltd., of Cambridge, Mass., and London, appointed Susan E. Bromley global head of R&D and named Kenneth B. Milne UK director of R&D

PolyMedix Inc., of Radnor, Pa., elected Richard Bank and Stefan Loren to its board...PPD Inc., of Wilmington, N.C., appointed Christine Dingivan executive vice president and chief medical officer

Alverix Inc., of San Jose, Calif., named James D. Merselis president and CEO, and a member of the board of directors...Amsterdam Molecular Therapeutics, of Amsterdam, the Netherlands, appointed Janneke de Wal director global marketing and sales

Alpharma Inc., of Bridgewater, N.J., appointed Ron Warner executive vice president and chief scientific officer and named R. Scott Shively senior vice president of pharmaceutical commercial operations...Althea Technologies Inc., of San Diego, named E. J. Brandreth vice president of quality and regulatory

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board